Scientists from the Medical Center Jewish General Hospital in Montreal found that the drug pioglitazone That all over the world take hundreds of thousands of patients with type 2 diabetes increases the risk of developing bladder cancer . Pioglitazone It is used to control blood sugar levels.
It is noteworthy that similar medication rosiglitazone does not increase the risk of cancer. This type of cancer diagnosed each year, about 20 thousand inhabitants of Russia. Every year, this type of cancer is dying a little more than 5 000 persons, and to live more than five years after the diagnosis is possible only 50%. Researchers from Canada found that when taken regularly pioglitazone the risk of this type of tumor is increased by 83%. If the medicine is taken for more than two years, the risk increases by 88%.
The researchers examined the medical records of more than 115 thousand people over 40 years old who are just starting pioglitazone therapy. Observations of them lasted for four and a half years, on average. As reported in the journal British Medical Journal, "the results allow to state that the use of pioglitazone significantly increases the risk of developing bladder cancer . "In Russian incidence of this type of tumor is approximately 70 cases per 100,000 people. Pioglitazone and rosiglitazone, as stated previously, also increase the risk of developing heart failure.
Industry News
Go back to the main page
Немає коментарів:
Дописати коментар